Literature DB >> 23352786

FIRST: Fractional Flow Reserve and Intravascular Ultrasound Relationship Study.

Ron Waksman1, Jacek Legutko, Jasvindar Singh, Quentin Orlando, Steven Marso, Timothy Schloss, John Tugaoen, James DeVries, Nicholas Palmer, Michael Haude, Stacy Swymelar, Rebecca Torguson.   

Abstract

OBJECTIVES: FIRST (Fractional Flow Reserve and Intravascular Ultrasound Relationship Study) aimed to determine the optimal minimum lumen area (MLA) by intravascular ultrasound (IVUS) that correlates with fractional flow reserve (FFR) and to assess the correlation between virtual histology IVUS and FFR for intermediate coronary lesions.
BACKGROUND: FFR is considered the gold standard for assessing intermediate coronary lesions. Measurements of ≤0.8 are considered clinically significant and indicative of physiological ischemia.
METHODS: FIRST is a multicenter, prospective, international registry of patients with intermediate coronary lesions, defined as 40% to 80% stenosis by angiography. In total, 350 patients (367 lesions) were enrolled at 10 U.S. and European sites. Patients were followed through hospital discharge.
RESULTS: Overall, an MLA <3.07 mm(2) (64.0% sensitivity, 64.9% specificity, area under curve [AUC] = 0.65) was the best threshold value for identifying FFR <0.8. The accuracy improved when reference vessel-specific analyses were performed. An MLA <2.4 mm(2) (AUC = 0.66) was best for reference vessel diameters <3.0 mm, an MLA <2.7 mm(2) (AUC = 0.71) for reference vessel diameters of 3.0 to 3.5 mm, and an MLA <3.6 mm(2) (AUC = 0.68) for reference vessel diameters >3.5 mm. FFR correlated with plaque burden (r = -0.220, p < 0.001) but not with other plaque morphology.
CONCLUSIONS: Anatomic measurements by IVUS show a moderate correlation with the FFR values. The optimal cutoff for an MLA to FFR <0.8 is vessel dependent. Plaque morphology characteristics do not correlate with FFR. The utility of IVUS MLA as an alternative to FFR to guide intervention in intermediate lesions may be limited in accuracy and should be tested clinically. (Fractional Flow Reserve and Intravascular Ultrasound Relationship Study [FIRST]; NCT01153555).
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23352786     DOI: 10.1016/j.jacc.2012.12.012

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  44 in total

1.  Segmental assessments of coronary plaque morphology and composition by virtual histology intravascular ultrasound and fractional flow reserve.

Authors:  Ju-Hyun Chung; Soe Hee Ann; Gillian Balbir Singh; Chang-Wook Nam; Joon-Hyung Doh; Hyung Il Kim; Bon-Kwon Koo; Eun-Seok Shin
Journal:  Int J Cardiovasc Imaging       Date:  2015-10-23       Impact factor: 2.357

2.  Method for percutaneously introducing, and removing, anatomical stenosis of predetermined severity in vivo: the "stenotic stent".

Authors:  Nicolas Foin; Sayan Sen; Ricardo Petraco; Sukhjinder Nijjer; Ryo Torii; Chrysa Kousera; Christopher Broyd; Vikram Mehta; Yun Xu; Jamil Mayet; Alun Hughes; Carlo Di Mario; Rob Krams; Darrel Francis; Justin Davies
Journal:  J Cardiovasc Transl Res       Date:  2013-06-04       Impact factor: 4.132

Review 3.  Clinical Application of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention for Stable Coronary Artery Disease.

Authors:  Valay Parikh; Kanishk Agnihotri; Sabeeda Kadavath; Nileshkumar J Patel; J Dawn Abbott
Journal:  Curr Cardiol Rep       Date:  2016-04       Impact factor: 2.931

4.  Influence of plaque characteristics on fractional flow reserve for coronary lesions with intermediate to obstructive stenosis: insights from integrated-backscatter intravascular ultrasound analysis.

Authors:  Shinichiro Sakurai; Hiroaki Takashima; Katsuhisa Waseda; Masahiko Gosho; Akiyoshi Kurita; Hirohiko Ando; Kazuyuki Maeda; Akihiro Suzuki; Masanobu Fujimoto; Tetsuya Amano
Journal:  Int J Cardiovasc Imaging       Date:  2015-07-01       Impact factor: 2.357

5.  Current use of fractional flow reserve: a nationwide survey.

Authors:  Bashar Hannawi; Wilson W Lam; Suwei Wang; George A Younis
Journal:  Tex Heart Inst J       Date:  2014-12-01

6.  Impact of two formulas to calculate percentage diameter stenosis of coronary lesions: from stenosis models (phantom lesion model) to actual clinical lesions.

Authors:  Alexandre Hideo-Kajita; Samuel Wopperer; Solomon S Beyene; Yael F Meirovich; Gebremedhin D Melaku; Kayode O Kuku; Echo J Brathwaite; Yuichi Ozaki; Kazuhiro Dan; Rebecca Torguson; Ron Waksman; Hector M Garcia-Garcia
Journal:  Int J Cardiovasc Imaging       Date:  2019-07-27       Impact factor: 2.357

7.  Association of quantitative flow ratio-derived microcirculatory indices with anatomical-functional discordance in intermediate coronary lesions.

Authors:  Liang Geng; Yuan Yuan; Peizhao Du; Liming Gao; Yunkai Wang; Jiming Li; Wei Guo; Ying Huang; Qi Zhang
Journal:  Int J Cardiovasc Imaging       Date:  2021-05-31       Impact factor: 2.357

Review 8.  A systematic review of imaging anatomy in predicting functional significance of coronary stenoses determined by fractional flow reserve.

Authors:  Miao Chu; Neng Dai; Junqing Yang; Jelmer Westra; Shengxian Tu
Journal:  Int J Cardiovasc Imaging       Date:  2017-03-06       Impact factor: 2.357

Review 9.  Impact of plaque characteristics on the degree of functional stenosis.

Authors:  Pedro de Araújo Gonçalves; Alexandre Hideo-Kajita; Hector Manuel Garcia-Garcia
Journal:  Cardiovasc Diagn Ther       Date:  2017-04

10.  Comparison between minimum lumen cross-sectional area and intraluminal ultrasonic intensity analysis using integrated backscatter intravascular ultrasound for prediction of functionally significant coronary artery stenosis.

Authors:  Hironori Takami; Shinjo Sonoda; Yoshitaka Muraoka; Toshiya Miura; Akiyoshi Shimizu; Reo Anai; Yoshinori Sanuki; Tetsu Miyamoto; Yasushi Oginosawa; Yoshihisa Fujino; Yuki Tsuda; Masaru Araki; Yutaka Otsuji
Journal:  Heart Vessels       Date:  2018-07-30       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.